Contineum Therapeutics, Inc. ( CTNM) - Key Metrics
CTNM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.40 | -$0.31 | -$0.31 |
| 2026Q1 | $0 | -$0.39 | -$0.44 | -$0.44 |
| 2025Q4 | $0 | -$0.49 | -$0.42 | -$0.42 |
| 2025Q3 | $0 | -$0.45 | -$0.43 | -$0.44 |
| 2025Q2 | $0 | -$0.62 | -$0.60 | -$0.61 |
CTNM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.24 |
| 2026Q1 | 0% | -8.37 |
| 2025Q4 | 0% | -5.83 |
| 2025Q3 | 0% | -6.53 |
| 2025Q2 | 0% | -1.60 |
CTNM
Price: $16.02
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 545.1 million